Candomore Tablet 32 mg (Candesartan Cilexetil)

Adult dose

Essential Hypertension The recommended initial and maintenance dose is 8 to 16 mg of Candesartan Cilexetil taken orally once daily. If blood pressure is not controlled after 4 weeks of treatment at a dose of 16 mg once daily, the dose may be increased up to 32 mg once daily. For patients with reduced intravascular effective blood volume and kidney disease, an initial dose of 4 mg should be administered; patients with liver dysfunction should start with an initial dose of 2 mg once daily. Heart Failure The initial dose is 1

Child dose

The safety and efficacy for adolescents and children under the age of 18 have not been established.

This drug can cause serious harm, particularly to the fetus and newborn, during pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug, women who are pregnant or breastfeeding, patients with severe liver disease or cholestasis, patients with hereditary angioedema, and patients with certain genetic lactose intolerance should avoid taking this medication. Elderly patients, those with hyperkalemia, liver dysfunction, heart valve disease, ischemic heart disease, and kidney disease should use this drug with caution and closely monitor their condition before and during administration. Common side effects of this drug include dizziness, back pain, respiratory infections, while serious side effects may rarely include severe liver dysfunction, blood disorders, skin rash, muscle pain, and worsening kidney function. In patients with heart failure, blood pressure reduction, hyperkalemia, and kidney function impairment may occur, necessitating regular blood tests and monitoring. The effect of this drug may be enhanced when used with other antihypertensive agents, so caution should be exercised regarding interactions with other medications being taken. Particularly, when used in combination with potassium-sparing diuretics or potassium supplements, serum potassium levels may rise dangerously, and caution is necessary. Women who are pregnant or planning to become pregnant should avoid using this drug, and it is advisable to avoid administering it while breastfeeding. The safety of this drug in children and adolescents under the age of 18 has not been established, so caution is needed in its use. In cases of overdose, hypotension, dizziness, and tachycardia may occur, and if symptoms are severe, immediate medical treatment should be sought. This medication should be kept out of reach of children, and it is important not to transfer it to another container to maintain quality. Caution should be taken as dizziness may occur when driving or operating machinery.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, peeling skin, pain in the mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory abnormalities accompanied by cough and fever, yellowing of the skin or eyes (jaundice), severe general fatigue, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis,

Mild side effects

Dizziness, back pain, respiratory infections (upper respiratory infection, pharyngitis, rhinitis), fatigue, peripheral edema, chest pain, headache, bronchitis, cough, sinusitis, nausea, abdominal pain, diarrhea, vomiting, joint pain, proteinuria, weakness, fever, sensory disturbances, dyspepsia, gastroenteritis, tachycardia, palpitations, creatine kinase (CK) increase, hyperglycemia, hypertriglyceridemia, hyperuricemia, muscle pain, epistaxis, anxiety, depression, drowsiness, dyspnea, rash,

This drug should be stored in a closed container to protect it from air and moisture. It is important to maintain storage temperatures between 1 and 30 degrees Celsius.

Appearance

Light pink, double convex, round tablet

Package unit

28 tablets (14 tablets/PTP X 2)